亮晴控股(08603.HK)涨3.52%，报6.7600港元，股价创历史新高，总市值55.36亿港元。 本文源自：金融界AI电报 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2026年1月31日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 亮晴控股有限公司 | | | | 呈交日期: | 2026年2月2日 | | | | I. 法定/註冊股本變動 | | | | 本月底法定/註冊股本總額： HKD 100,000,000 FF301 第 1 頁 共 10 頁 v 1.2.0 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08603 | 說明 | 亮晴控股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 ...

董事会欣然宣布，朱浚霆先生(朱先生)已获委任为公司秘书，自2026年1月26日起生效。 亮晴控股(08603)发布公告，谭芷欣女士(谭女士)已辞任本公司的公司秘书(公司秘书)，自2026年1月26日 起生效。 董事会进一步宣布，自2026年1月26日起，执行董事符芷晴女士不再担任香港联合交易所有限公司GEM 证券上市规则第5.24条项下本公司授权代表(授权代表)。朱先生已获委任为授权代表，自2026年1月26日 起生效。 ...

董事会欣然宣布，朱浚霆先生(朱先生)已获委任为公司秘书，自2026年1月26日起生效。 智通财经APP讯，亮晴控股(08603)发布公告，谭芷欣女士(谭女士)已辞任本公司的公司秘书(公司秘 书)，自2026年1月26日起生效。 董事会进一步宣布 ，自2026年1月26日起，执行董事符芷晴女士不再担任香港联合交易所有限公司GEM 证券上市规则第5.24条项下本公司授权代表(授权代表)。朱先生已获委任为授权代表，自2026年1月26日 起生效。 ...

格隆汇1月26日丨亮晴控股(08603.HK)公告，谭芷欣已辞任公司秘书，自2026年1月26日起生效。朱浚霆 已获委任为公司秘书，自2026年1月26日起生效。 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或 任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Fameglow Holdings Limited 亮 晴 控 股 有 限 公 司 亮晴控股有限公司（「本公司」）之董事會（「董事會」）謹此公佈，譚芷欣女士（「譚女 士 」）已 辭 任 本 公 司 之 公 司 秘 書（「 公 司 秘 書 」）， 自 二 零 二 六 年 一 月 二 十 六 日 起 生 效。譚女士已確認，彼與董事會之間並無意見分歧，且概無與其辭任有關之事宜 須提請香港聯合交易所有限公司（「聯交所」）及本公司股東垂注。 董事會欣然宣佈，朱浚霆先生（「朱先生」）已獲委任為公司秘書，自二零二六年一 月二十六日起生效。朱先生為香港會計師公會會員。彼持有香港浸會大學會計學 工商管理學士學位。彼亦在企業管治、財務及會計領域擁有豐富的工作經驗。 董事會藉此機會衷心感謝譚女士於其任職期間為本公司做出的寶貴貢獻及提供的 服務並歡迎朱先生履新。 ...

Summary of Key Points Core Viewpoint - As of January 9, a total of 73 stocks reached their 52-week highs, with notable performances from Lingxiong Technology (02436), Delai Construction (01546), and Zhipu (02513) showing significant growth rates of 104.99%, 38.89%, and 22.22% respectively [1]. 52-Week Highs - Lingxiong Technology (02436) closed at 11.760, with a peak price of 15.600, achieving a high rate of 104.99% [1]. - Delai Construction (01546) closed at 0.161, reaching a maximum of 0.250, with a high rate of 38.89% [1]. - Zhipu (02513) had a closing price of 158.600 and a peak of 165.000, resulting in a high rate of 22.22% [1]. - Other notable stocks include Asia Pacific Satellite (01045) with a high rate of 20.64% and Rongda Technology (09881) at 12.87% [1]. 52-Week Lows - The stocks reaching their 52-week lows include Lishi International (00842) with a closing price of 0.850, marking a decline of 39.29% [2]. - Bokan Vision Cloud - B (02592) closed at 2.930, with a decrease of 16.90% [2]. - Lingzai Technology Finance (00093) reached a low of 0.485, reflecting a drop of 14.77% [2].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: 2025年12月31日 | | --- | | 狀態: | | 新提交 | 致：香港交易及結算所有限公司 公司名稱: 亮晴控股有限公司 呈交日期: 2026年1月2日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08603 | 說明 | 亮晴控股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 | HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.01 | HKD | | 100,000,0 ...

Key Points - As of December 19, 38 stocks reached their 52-week highs, with Li Gao Health Life (02370), Ginkgo Education (01851), and Kangqiao Yuelife (02205) leading the high rate at 36.36%, 18.72%, and 8.70% respectively [1] - The top three stocks that achieved new highs are as follows: - Li Gao Health Life (02370) closed at 0.670, with a peak of 0.750, marking a 36.36% increase - Ginkgo Education (01851) closed at 2.430, with a peak of 2.600, marking an 18.72% increase - Kangqiao Yuelife (02205) closed at 1.200, with a peak of 1.250, marking an 8.70% increase [1] - Other notable stocks that reached new highs include Liangqing Holdings (1,000) at 7.14%, Jinxing International Holdings (02307) at 7.04%, and Wuxi Life (08148) at 6.21% [1] 52-Week Low Summary - The 52-week low rankings show that Haowen Holdings (08019) had the largest decline at -16.13%, closing at 0.130 [2] - Other significant declines include NIU Holdings (08619) at -11.86%, closing at 0.156, and Hashkey HLDGS (03887) at -9.59%, with a low of 5.090 [2] - Additional stocks with notable declines include Songdu Service (09608) at -9.09%, closing at 0.068, and Ruike Bio-B (02179) at -5.41%, closing at 5.070 [2]

Financial Performance - For the six months ended September 30, 2025, the group's revenue was approximately HKD 284.6 million, a significant increase of 68.5% compared to HKD 169.5 million for the same period in 2024[8]. - The net profit for the same period was approximately HKD 20.8 million, representing a 26.5% increase from HKD 16.4 million in the previous year[8]. - The group reported a basic earnings per share of HKD 2.61, up from HKD 2.05 in the previous year, reflecting improved profitability[9]. - For the six months ended September 30, 2025, the company reported a profit of 20,840,000 HKD, compared to 16,430,000 HKD for the same period in 2024, representing a year-over-year increase of 27.5%[12]. - Revenue from treatment services reached 280,404,000 HKD, a significant increase of 71.7% compared to 163,302,000 HKD in the previous year[18]. - Net profit for the same period was approximately HKD 20.8 million, up from HKD 16.4 million in the previous year, primarily due to increased revenue[49]. Dividends and Shareholder Information - The board of directors did not recommend the distribution of dividends for the six months ended September 30, 2025, consistent with the previous year[8]. - The company did not declare any dividends for the six months ended September 30, 2025, consistent with the previous year[23]. - The major shareholders, Mr. Ye and Ms. Fu, each hold 63.28% of the company's shares through a controlled corporation, totaling 506,200,000 shares[71]. - Equal Joy holds 506,200,000 shares, representing 63.28% of the company's equity[74]. Assets and Liabilities - Total assets as of September 30, 2025, amounted to HKD 330.3 million, up from HKD 329.8 million as of March 31, 2025[10]. - Current liabilities decreased to HKD 186.4 million from HKD 176.9 million as of March 31, 2025, indicating improved liquidity management[11]. - The group's total equity increased to HKD 126.9 million from HKD 106.1 million, indicating a stronger financial position[11]. - The total outstanding debt as of September 30, 2025, was approximately HKD 131.6 million, including lease liabilities of HKD 80.4 million and bank borrowings of HKD 51.2 million[50]. - The debt-to-equity ratio was 103.7% as of September 30, 2025, up from 87.1% as of March 31, 2025[60]. Operational Highlights - The group’s inventory increased to HKD 22.5 million from HKD 10.8 million, reflecting a strategic buildup of stock to meet anticipated demand[10]. - Trade receivables rose to HKD 87.8 million from HKD 80.9 million, suggesting an increase in sales and customer base[10]. - The company opened several new centers to expand its operations, including two new premium centers in Tsim Sha Tsui and Central in April 2023, and plans to open additional centers in various locations by March 31, 2025[38]. - The company launched a new brand "perFACE ESSENTIAL" in 2025, which combines innovative medical technology and expertise to offer a variety of treatment solutions[38]. Employee and Operational Costs - The company incurred total employee costs of 115,856,000 HKD, which is an increase of 90% from 61,059,000 HKD in the previous year[21]. - Employee costs for the six months ended September 30, 2025, were approximately HKD 115.9 million, an increase from HKD 61.1 million in the previous year, mainly due to a rise in the number of employees[44]. - Other expenses for the same period totaled approximately HKD 69.2 million, up from HKD 41.3 million, driven by increased marketing activities and consultation fees paid to doctors[48]. Cash Flow and Financing - The company recorded a net cash outflow from operating activities of 17,571,000 HKD for the six months ended September 30, 2025, compared to a net inflow of 45,283,000 HKD in the same period of 2024[13]. - Total cash and cash equivalents at September 30, 2025, were 40,516,000 HKD, a decrease from 40,615,000 HKD at the beginning of the period[13]. - The company incurred financing costs of HKD 2.0 million, an increase from HKD 1.2 million, which may indicate higher borrowing levels[9]. Governance and Compliance - The group maintained compliance with corporate governance codes and has established an audit committee to oversee financial reporting[67][69]. - The board of directors includes executive and independent non-executive members, ensuring diverse governance[87]. - No directors or their associates are engaged in any business that directly or indirectly competes with the group's business, maintaining compliance with GEM listing rules[87]. Stock Options and Share Plans - The stock option plan allows for a maximum of 80,000,000 shares to be granted, which is 10% of the issued shares as of the report date[76]. - No stock options have been granted, exercised, or canceled since the adoption of the stock option plan[83]. - The stock option plan is valid for ten years from the date of adoption unless terminated by shareholder resolution[76]. - The exercise price of each stock option must be at least the higher of the closing price on the grant date or the average closing price over the five trading days prior to the offer date[82]. - The company has no outstanding stock options, warrants, or convertible securities as of September 30, 2025[83].